or Try an Advanced Search...

    Technical Analysis for DMTK - DermTech, Inc.

    Grade Last Price % Change Price Change
    F 0.62 -2.76% -0.02
    DMTK closed up 2.4 percent on Wednesday, May 8, 2024, on 28 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.
    3 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Down Up
    Historical DMTK trend table...
    Date Alert Name Type % Chg
    Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -2.76%
    Bollinger Band Squeeze Range Contraction -2.76%
    NR7 Range Contraction -2.76%
    BB Squeeze + Upper Band Touch Range Contraction -2.76%
    Inside Day Range Contraction -2.76%
    Upper Bollinger Band Touch Strength -2.76%
    Shooting Star Candlestick Bearish -0.43%
    Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -0.43%
    20 DMA Support Bullish -0.43%
    Bollinger Band Squeeze Range Contraction -0.43%
    Older End-of-Day Signals for DMTK ...

       Recent Intraday Alerts

    Alert Time
    Possible NR7 about 1 hour ago
    Fell Below 20 DMA about 3 hours ago
    Fell Below 10 DMA about 5 hours ago
    20 DMA Support about 5 hours ago
    10 DMA Support about 5 hours ago
    View Earlier Intraday Alerts

    Free Daily (Stock) Chart Reading

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Analyze My Stocks!
    Configure default chart indicators
    DMTK Chart by TradingView
    Basic chart:

    Profile

    DermTech, Inc. Description

    DermTech, Inc., a molecular diagnostic company, develops and markets novel non-invasive diagnostic tests to diagnosis skin cancer and related conditions in the United States. The company offers Pigmented Lesion Assay (PLA), a gene expression test that helps rule out melanoma and the need for a surgical biopsy of atypical pigmented lesions. It also provides Nevome test, an adjunctive reflex test for the PLA; and adhesive skin sample collection kits, as well as gene expression assays for the Th1, Th2, IFN-gamma, and Th17 inflammatory pathways. The company is also developing non-melanoma skin cancer diagnostic and non-melanoma skin cancer risk assessment products. The company sells its products primarily to pathology and oncology practitioners. DermTech, Inc. is headquartered in La Jolla, California.

    Classification
    Sector: Industrials
    Industry: Conglomerates
    Keywords: Medicine Cancer Melanoma Dermatology Gene Expression Diagnostic Tests Risk Assessment Pathology Biopsy Skin Cancer Assessment Products Melanoma Skin Cancer Pigmented Lesion Cutaneous Conditions Non Melanoma Skin Cancer

    Is DMTK a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Apr 19 Cancer test maker Dermtech to cut 100 jobs, explore strategic options
    Apr 18 DermTech exploring strategic alternatives, cutting 56% of staff
    Apr 18 DermTech to Explore Strategic Alternatives and Implement Restructuring Plan
    Apr 1 DermTech Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    Mar 8 DermTech Presents Research Abstracts at the 2024 American Academy of Dermatology (AAD) Annual Meeting and New Research Published in the Journal of Investigative Dermatology
    Mar 3 DermTech, Inc. (NASDAQ:DMTK) Analysts Are Cutting Their Estimates: Here's What You Need To Know
    Mar 2 DermTech, Inc. (NASDAQ:DMTK) Q4 2023 Earnings Call Transcript
    Mar 1 DermTech, Inc. (DMTK) Q4 2023 Earnings Call Transcript
    Feb 29 DermTech, Inc. (DMTK) Reports Q4 Loss, Misses Revenue Estimates
    Feb 29 DermTech GAAP EPS of -$0.56 in-line, revenue of $3.92M misses by $0.11M
    See more DMTK news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 3.8939
    52 Week Low 0.572
    Average Volume 314,326
    200-Day Moving Average 1.44
    50-Day Moving Average 0.69
    20-Day Moving Average 0.62
    10-Day Moving Average 0.62
    Average True Range 0.05
    RSI (14) 47.64
    ADX 19.86
    +DI 13.93
    -DI 11.87
    Chandelier Exit (Long, 3 ATRs) 0.53
    Chandelier Exit (Short, 3 ATRs) 0.73
    Upper Bollinger Bands 0.66
    Lower Bollinger Band 0.58
    Percent B (%b) 0.81
    BandWidth 12.54
    MACD Line -0.02
    MACD Signal Line -0.04
    MACD Histogram 0.0128
    Fundamentals Value
    Market Cap 21.95 Million
    Num Shares 34.2 Million
    EPS -3.48
    Price-to-Earnings (P/E) Ratio -0.18
    Price-to-Sales 2.98
    Price-to-Book 0.57
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 0.69
    Resistance 3 (R3) 0.69 0.68 0.68
    Resistance 2 (R2) 0.68 0.66 0.68 0.68
    Resistance 1 (R1) 0.66 0.66 0.67 0.66 0.68
    Pivot Point 0.64 0.64 0.65 0.64 0.64
    Support 1 (S1) 0.62 0.63 0.63 0.62 0.60
    Support 2 (S2) 0.61 0.62 0.61 0.60
    Support 3 (S3) 0.59 0.61 0.60
    Support 4 (S4) 0.59